Centro Hospitalar Universitario Sao Joao. E.P.E

Porto 4200-139

1 studies enrolling now · 2 studies all time

What they study most

Indolent Systemic Mastocytosis, Myelodysplastic Syndromes, Smoldering Systemic Mastocytosis

Studies at this site

• (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis — Recruiting now
• Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) — Stopped early